Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1966 1
1967 1
1968 4
1969 19
1970 24
1971 24
1972 36
1973 17
1974 31
1975 30
1976 26
1977 30
1978 29
1979 27
1980 34
1981 30
1982 46
1983 42
1984 41
1985 33
1986 40
1987 19
1988 36
1989 29
1990 28
1991 24
1992 30
1993 22
1994 28
1995 30
1996 31
1997 35
1998 24
1999 24
2000 32
2001 28
2002 32
2003 29
2004 34
2005 23
2006 24
2007 36
2008 27
2009 23
2010 29
2011 37
2012 31
2013 30
2014 24
2015 37
2016 29
2017 43
2018 37
2019 34
2020 42
2021 31
2022 19
2023 35
2024 30
2025 38
2026 24

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,684 results

Results by year

Filters applied: . Clear all
Page 1
Insomnia: Pharmacologic Therapy.
Matheson E, Hainer BL. Matheson E, et al. Am Fam Physician. 2017 Jul 1;96(1):29-35. Am Fam Physician. 2017. PMID: 28671376 Free article. Review.
Understanding the risks and benefits of insomnia medications is critical. Controlled-release melatonin and doxepin are recommended as first-line agents in older adults; the so-called z-drugs (zolpidem, eszopiclone, and zaleplon) should be reserved for use if the first-line …
Understanding the risks and benefits of insomnia medications is critical. Controlled-release melatonin and doxepin are recommended as …
Trazodone-induced mania.
Lennhoff M. Lennhoff M. J Clin Psychiatry. 1987 Oct;48(10):423-4. J Clin Psychiatry. 1987. PMID: 3667543 No abstract available.
Dysmorphophobia.
Jenike MA. Jenike MA. Br J Psychiatry. 1985 Mar;146:326. doi: 10.1192/bjp.146.3.326a. Br J Psychiatry. 1985. PMID: 3986443 No abstract available.
Doxepin cream for eczema?
[No authors listed] [No authors listed] Drug Ther Bull. 2000 Apr;38(4):31-2. doi: 10.1136/dtb.2000.38431. Drug Ther Bull. 2000. PMID: 10845241 Review.
Traditionally, it is treated with emollients, topical corticosteroids or oral antihistamines. A topical form of the antidepressant doxepin (doxepin 5% cream; Xepin-Bioglan) is now marketed for "the relief of pruritus associated with eczema" in adults and children ag …
Traditionally, it is treated with emollients, topical corticosteroids or oral antihistamines. A topical form of the antidepressant doxepi …
Low-dose doxepin (Silenor) for insomnia.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2010 Oct 4;52(1348):79-80. Med Lett Drugs Ther. 2010. PMID: 20885342 Review. No abstract available.
Doxepin and tinnitus.
Golden RN, Evans DL, Nau CH Jr. Golden RN, et al. South Med J. 1983 Sep;76(9):1204-5. doi: 10.1097/00007611-198309000-00046. South Med J. 1983. PMID: 6612411
A 66-year-old woman had tinnitus while receiving a conventional dose of doxepin. The tinnitus disappeared when the doxepin was discontinued, and returned when the patient was rechallenged with the drug....
A 66-year-old woman had tinnitus while receiving a conventional dose of doxepin. The tinnitus disappeared when the doxepin was …
Doxepin hydrochloride.
Hollister LE. Hollister LE. Ann Intern Med. 1974 Sep;81(3):360-3. doi: 10.7326/0003-4819-81-3-360. Ann Intern Med. 1974. PMID: 4604347 Clinical Trial. No abstract available.
Doxepin poisoning.
Oliver JS, Watson AA. Oliver JS, et al. Med Sci Law. 1974 Oct;14(4):280-3. doi: 10.1177/002580247401400408. Med Sci Law. 1974. PMID: 4444463 No abstract available.
Doxepin-cholestyramine interaction.
Geeze DS, Wise MG, Stigelman WH Jr. Geeze DS, et al. Psychosomatics. 1988 Spring;29(2):233-6. doi: 10.1016/S0033-3182(88)72405-6. Psychosomatics. 1988. PMID: 3368570 No abstract available.
Low-dose doxepin: in the treatment of insomnia.
Weber J, Siddiqui MA, Wagstaff AJ, McCormack PL. Weber J, et al. CNS Drugs. 2010 Aug;24(8):713-20. doi: 10.2165/11200810-000000000-00000. CNS Drugs. 2010. PMID: 20658801 Review.
Symptom control was maintained for up to 12 weeks of low-dose doxepin administration and there was no evidence of physical dependence or worsening insomnia after doxepin withdrawal. ...Oral, low-dose doxepin was generally well tolerated in clinical trials....
Symptom control was maintained for up to 12 weeks of low-dose doxepin administration and there was no evidence of physical dependence …
1,684 results